| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |